We are pleased to announce that we will participate as an event partner at the 5th Oligonucleotides for CNS Summit, taking place in Boston from August 27 to 29, 2025. 

On August 27 at 1:30 p.m. local time, Hideaki Tomita, Group Lead of the Biology, R&D Division, will present “Opening (therapeutic) window: Application of GuNA and 5’CP to improve potency and cytotoxicity in CNS therapy.” 

We look forward to seeing you there. 

For more details, please click here.